News | Clavystbio

In the News

09 Aug, 2023

Portfolio

Sunbird Bio Snaps Up Glympse Bio for Protein-based Diagnostics

08 Aug, 2023

ClavystBio

Khoo Shih named CEO of Singapore’s ClavystBio

25 Apr, 2023

ClavystBio

Could Singapore become the next global biotech hub?

04 Apr, 2023

Portfolio

The Future of Everything: Bats Shrug Off Viruses and Rarely Get Cancer. We're Trying To Learn From Them.

27 Feb, 2023

Portfolio

What can bats, naked mole rats and Jaws tell us about human biology? Paratus is on a $100M mission to find out.

25 Feb, 2023

Portfolio

Paratus: Leveraging Bat Biology to Improve Human Health

30 Nov, 2022

Portfolio

Founder of Sunbird Bio spearheads the development of groundbreaking tests for earlier detection of dementia

15 Sep, 2022

ClavystBio

Temasek's CLA Real Estate sets up life sciences investment company

15 Sep, 2022

ClavystBio

CLA Real Estate Holdings establishes ClavystBio to accelerate bioscience commercialization

15 Sep, 2022

ClavystBio

Life sciences company ClavystBio launches with aim to 'accelerate' industry in Singapore

Press Releases

27 Sep 2023

Portfolio

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

09 Aug 2023

Portfolio

Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies

08 Mar 2023

Portfolio

Paratus Sciences Launches with $100M Series A Financing to Develop Novel Therapeutics Based on the Unique Biology of Bats